Fremont, CA, United States of America

Mahmoud Ameri

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 146(Granted Patents)


Company Filing History:


Years Active: 2009-2023

Loading Chart...
Loading Chart...
16 patents (USPTO):

Title: The Innovative Contributions of Mahmoud Ameri

Introduction

Mahmoud Ameri is a notable inventor based in Fremont, California, recognized for his significant contributions to the field of migraine treatment. With a total of 16 patents to his name, Ameri has developed innovative methods and devices aimed at improving the therapeutic delivery of triptans, a class of medications used to treat migraines.

Latest Patents

Among his latest patents is a method for rapidly achieving therapeutic concentrations of triptans for the treatment of migraines. This patent describes compositions, devices, and methods that employ therapeutic concentrations of a triptan, specifically zolmitriptan, to achieve relief as quickly as 2 minutes and not later than 30 minutes in the majority of subjects. Another patent focuses on a similar method for treating both migraines and cluster headaches, emphasizing the efficiency and speed of delivery.

Career Highlights

Throughout his career, Ameri has worked with prominent companies such as Alza Corporation and Emergex USA Corporation. His work in these organizations has allowed him to refine his inventions and contribute to advancements in medical technology.

Collaborations

Some of his notable coworkers include Peter E. Daddona and Michel J. N. Cormier, who have collaborated with Ameri on various projects, enhancing the scope and impact of his innovations.

Conclusion

Mahmoud Ameri's work in developing rapid delivery methods for migraine treatment showcases his dedication to improving patient care through innovation. His contributions continue to influence the medical field and provide relief to those suffering from migraines.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…